CTOs on the Move

OmniSonics Medical Technologies

www.omnisonics.com

 
At OmniSonics, we are a team of highly dedicated people focused on building technology that will allow physicians to improve the quality of life for patients suffering from vascular diseases - such as deep vein thrombosis (DVT) and peripheral arterial
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Northwestern Memorial Hospital

Northwestern Memorial Hospital (NMH) is one of the country's premier academic medical centers and is the primary teaching hospital of Northwestern University's Feinberg School of Medicine.

BROWNING'S PHARMACY

BROWNING'S PHARMACY is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Melbourne, FL. To find more information about BROWNING'S PHARMACY, please visit www.brownings.net

BERTRAND CHAFFEE HOSPITAL

BERTRAND CHAFFEE HOSPITAL is a Springville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CytRx Corporation

CytRx Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Los Angeles, CA. To find more information about CytRx Corporation, please visit www.cytrx.com

OncoCell MDx

OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.